Severe vivax malaria: a prospective exploration at a tertiary healthcare centre in Southwestern India

References

• World Health Organization. World malaria report. Geneva: World Health Organization; 2015.
   Google Scholar
• Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–1070. 10.1016/S0140-6736(14)60844-8
   PubMed Web of Science ®Google Scholar
• Price RN, Tjitra E, Guerra CA, et al. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77(Suppl:6):79–87.
   PubMed Web of Science ®Google Scholar
• Guerra CA, Snow RW, Hay SI. Mapping the global extent of malaria in 2005. Trends Parasitol. 2006;22(8):353–358. 10.1016/j.pt.2006.06.006
   PubMed Web of Science ®Google Scholar
• Hay SI, Guerra CA, Tatem AJ, et al. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004;4(6):327–336. 10.1016/S1473-3099(04)01043-6
   PubMed Web of Science ®Google Scholar
• Mendis K, Sina BJ, Marchesini P, et al. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64(Suppl: 1–2):97–106.
   PubMed Web of Science ®Google Scholar
• Das A, Anvikar AR, Cator LJ, et al. Malaria in India: the center for the study of complex malaria in India. Acta Trop. 2012;121(3):267–273.
   PubMed Web of Science ®Google Scholar
• Joshi H, Prajapati SK, Verma A, et al. Plasmodium vivax in India. Trends Parasitol. 2008;24(5):228–235. 10.1016/j.pt.2008.01.007
   PubMed Web of Science ®Google Scholar
• Saravu K, Kumar R, Ashok H, et al. Therapeutic assessment of Chloroquine-Primaquine combined regimen in adult cohort of plasmodium vivax malaria from primary care centres in Southwestern India. PLoS One. 2016;11(6):e0157666. 10.1371/journal.pone.0157666
   Google Scholar
• Dhingra N, Jha P, Sharma VP, et al. Adult and child malaria mortality in India: a nationally representative mortality survey. Lancet. 2010;376(9754):1768–1774. 10.1016/S0140-6736(10)60831-8
   PubMed Web of Science ®Google Scholar
• Hay SI, Gething PW, Snow RW. India’s invisible malaria burden. Lancet. 2010;376(9754):1716–1717. 10.1016/S0140-6736(10)61084-7
   PubMed Web of Science ®Google Scholar
• World Health Organization. Severe malaria. Trop Med Int Health. 2014;19(Suppl: 1):7–131.
   Google Scholar
• World Health Organization. Guidelines for the treatment of malaria. Geneva: Switzerland; 2015.
   Google Scholar
• Directorate of National Vector Borne Disease Control Programme. National drug policy on malaria. Directorate General of Health Services: Ministry of Health and Family Welfare; 2013.
   Google Scholar
• World Health Organization. World malaria report. Geneva: World Health Organization; 2013.
   Google Scholar
• Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22(1):13–36. 10.1128/CMR.00025-08
   PubMed Web of Science ®Google Scholar
• Cassiano GC, Furini AA, Capobianco MP, et al. Polymorphisms in B Cell co-stimulatory genes are associated with IgG antibody responses against blood-stage proteins of plasmodium vivax. PLoS One. 2016;11(2):e0149581. 10.1371/journal.pone.0149581
   Google Scholar
• Driss A, Hibbert JM, Wilson NO, et al. Genetic polymorphisms linked to susceptibility to malaria. Malar J. 2011;10:271. 10.1186/1475-2875-10-271
   PubMed Web of Science ®Google Scholar
• Mendonca VR, Souza LC, Garcia GC, et al. DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria. Malar J. 2014;13:278. 10.1186/1475-2875-13-278
   PubMed Web of Science ®Google Scholar
• Saravu K, Rishikesh K, Kamath A, et al. Severity in Plasmodium vivax malaria claiming global vigilance and exploration-a tertiary care centre-based cohort study. Malar J. 2014;13(1):304. 10.1186/1475-2875-13-304
   PubMed Web of Science ®Google Scholar
• Gupta P, Sharma R, Chandra J, et al. Clinical manifestations and molecular mechanisms in the changing paradigm of vivax malaria in India. Infect Genet Evol. 2016;39:317–324. 10.1016/j.meegid.2016.02.014
   PubMed Web of Science ®Google Scholar
• Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26(1):36–57. 10.1128/CMR.00074-12
   PubMed Web of Science ®Google Scholar
• Chaparro-Narvaez PE, Lopez-Perez M, Rengifo LM, et al. Clinical and epidemiological aspects of complicated malaria in Colombia, 2007–2013. Malar J. 2016;15(1):269. 10.1186/s12936-016-1323-5
   PubMed Web of Science ®Google Scholar
• Valecha N, Pinto RGW, Turner GDH, et al. Histopathology of fatal respiratory distress caused by plasmodium vivax malaria. Am J Trop Med Hyg. 2009;81(5):758–762. 10.4269/ajtmh.2009.09-0348
   PubMed Web of Science ®Google Scholar
• Beg MA, Khan R, Baig SM, et al. Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg. 2002;67(3):230–232.
   PubMed Web of Science ®Google Scholar
• Lomar AV, Vidal JE, Lomar FP, et al. Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz J Infect Dis. 2005;9(5):425–430.
   PubMedGoogle Scholar
• Sarkar S, Bhattacharya P. Cerebral malaria caused by Plasmodium vivax in adult subjects. Indian J Crit Care Med. 2008;12(4):204–205. 10.4103/0972-5229.45084
   PubMedGoogle Scholar
• Poels PJ, Dolmans WM, Gabreels FJ. Rhabdomyolysis associated with malaria tertiana in a patient with myoadenylate deaminase deficiency. Trop Geogr Med. 1993;45(2):83–86.
   PubMedGoogle Scholar
• Sharma J, Bharadawa K, Shah K, et al. Plasmodium vivax malaria presenting as hemolytic–uremic syndrome. Indian Pediatr. 1993;30(3):369–371.
   PubMedGoogle Scholar
• Tilluckdharry CC, Chadee DD, Doon R, et al. A case of vivax malaria presenting with psychosis. West Indian Med J. 1996;45(1):39–40.
   PubMed Web of Science ®Google Scholar
• Islam N, Qamruddin K. Unusual complications in benign tertian malaria. Trop Geogr Med. 1995;47(3):141–143.
   PubMedGoogle Scholar
• Perren A, Beretta F, Schubarth P. ARDS in plasmodium vivax malaria. Schweiz Med Wochenschr. 1998;128(25):1020–1023.
   PubMedGoogle Scholar
• Torres JR, Perez H, Postigo MM, et al. Acute non-cardiogenic lung injury in benign tertian malaria. Lancet. 1997;350(9070):31–32. 10.1016/S0140-6736(05)66241-1
   PubMed Web of Science ®Google Scholar
• Saravu K, Rishikesh K, Parikh CR. Risk factors and outcomes stratified by severity of acute kidney injury in malaria. PLoS One. 2014;9(3):e90419. 10.1371/journal.pone.0090419
   Google Scholar
• Saravu K, Rishikesh K, Kamath A. Determinants of mortality, intensive care requirement and prolonged hospitalization in malaria – a tertiary care hospital based cohort study from South-Western India. Malar J. 2014;13:370. 10.1186/1475-2875-13-370
   PubMed Web of Science ®Google Scholar
• Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5(6):e128. 10.1371/journal.pmed.0050128
   PubMed Web of Science ®Google Scholar
• Quispe AM, Pozo E, Guerrero E, et al. Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg. 2014;91(1):11–17. 10.4269/ajtmh.12-0610
   PubMed Web of Science ®Google Scholar
• Rishikesh K, Kamath A, Hande MH, et al. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. Malar J. 2015;14:310. 10.1186/s12936-015-0824-y
   PubMed Web of Science ®Google Scholar
• Rishikesh K, Madivala SK, Prabhu P, et al. Surmised total leucocyte counts miscalculate the parasite index of Plasmodium vivax malaria patients of tertiary and primary care settings in South-Western India. Malar J. 2015;14(1):163.10.1186/s12936-015-0669-4
   PubMed Web of Science ®Google Scholar
• World Health Organization. A practical handbook – management of severe malaria. Geneva: World Health Organization; 2012.
   Google Scholar
• World Health Organization. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2010.
   Google Scholar
• Snounou G, Viriyakosol S, Zhu XP, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993; 61(2):315–320. 10.1016/0166-6851(93)90077-B
   PubMed Web of Science ®Google Scholar
• WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009.
   Google Scholar
• Shalini S, Chaudhuri S, Sutton PL, et al. Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India. Malar J. 2014;13:129. 10.1186/1475-2875-13-129
   PubMed Web of Science ®Google Scholar
• Rajgor, D, Gogtay N, Kadam V, et al. Antirelapse efficacy of various primaquine regimens for plasmodium vivax. Malar Res Treat. 2014;2014.
   PubMedGoogle Scholar
• Nadkar MY, Huchche AM, Singh R, et al. Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai from June 2010 to January 2011. J Assoc Physicians India. 2012;60:11–13.
   PubMedGoogle Scholar
• Thanachartwet V, Desakorn V, Sahassananda D, et al. Acute renal failure in patients with severe falciparum malaria: using the WHO 2006 and RIFLE criteria. Int J Nephrol. 2013;2013:1–6. 10.1155/2013/841518
   Google Scholar
• Lon C, Timmermans A, Buathong N, et al. Severe malaria in Battambang Referral Hospital, an area of multidrug resistance in Western-Cambodia: a retrospective analysis of cases from 2006–2009. Malar J. 2013;12:217. 10.1186/1475-2875-12-217
   PubMed Web of Science ®Google Scholar
• Verhulst NO, Beijleveld H, Qiu YT, et al. Relation between HLA genes, human skin volatiles and attractiveness of humans to malaria mosquitoes. Infect Genet Evol. 2013;18:87–93. 10.1016/j.meegid.2013.05.009
   PubMed Web of Science ®Google Scholar
• Verhulst NO, Weldegergis BT, Menger D, et al. Attractiveness of volatiles from different body parts to the malaria mosquito Anopheles coluzzii is affected by deodorant compounds. Sci Rep. 2016;6:27141. 10.1038/srep27141
   PubMed Web of Science ®Google Scholar
• Mukabana WR, Takken W, Coe R, et al. Host-specific cues cause differential attractiveness of Kenyan men to the African malaria vector Anopheles gambiae. Malar J. 2002;1:17. 10.1186/1475-2875-1-17
   PubMedGoogle Scholar
• Verhulst NO, Qiu YT, Beijleveld H, et al. Composition of human skin microbiota affects attractiveness to malaria mosquitoes. PLoS One. 2011;6(12):e28991. 10.1371/journal.pone.0028991
   Google Scholar
• Verhulst NO, Andriessen R, Groenhagen U, et al. Differential attraction of malaria mosquitoes to volatile blends produced by human skin bacteria. PLoS One. 2010;5(12):e15829. 10.1371/journal.pone.0015829
   Google Scholar
• Lefevre T, Gouagna LC, Dabire KR, et al. Beer consumption increases human attractiveness to malaria mosquitoes. PLoS One. 2010;5(3):e9546. 10.1371/journal.pone.0009546
   Google Scholar
• Barber BE, William T, Grigg MJ, et al. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis. 2013;56(3):383–397. 10.1093/cid/cis902
   PubMed Web of Science ®Google Scholar
• Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101(9):3407–3412. 10.1182/blood-2002-05-1597
   PubMed Web of Science ®Google Scholar
• Abdallah TM, Abdeen MT, Ahmed IS, et al. Severe Plasmodium falciparum and Plasmodium vivax malaria among adults at Kassala Hospital, eastern Sudan. Malaria J. 2013;12:148. 10.1186/1475-2875-12-148
   PubMed Web of Science ®Google Scholar
• Marks M, Armstrong M, Walker D, et al. Imported falciparum malaria among adults requiring intensive care: analysis of the literature. Malaria J. 2014;13(1):79. 10.1186/1475-2875-13-79
   PubMed Web of Science ®Google Scholar
• Zubairi AB, Nizami S, Raza A, et al. Severe Plasmodium vivax malaria in Pakistan. Emerg Infect Dis. 2013;19(11):1851–1854. 10.3201/eid1911.130495
   PubMed Web of Science ®Google Scholar
• Ganguly S, Saha P, Guha SK, et al. High prevalence of asymptomatic malaria in a tribal population in eastern India. J Clin Microbiol. 2013;51(5):1439–1444. 10.1128/JCM.03437-12
   PubMed Web of Science ®Google Scholar
• Limaye CS, Londhey VA, Nabar ST. The study of complications of vivax malaria in comparison with falciparum malaria in Mumbai. J Assoc Physicians India. 2012;60:15–18.
   PubMedGoogle Scholar
• Sarkar D, Ray S, Saha M, et al. Clinico-laboratory profile of severe Plasmodium vivax malaria in a tertiary care centre in Kolkata. Trop Parasitol. 2013;3(1):53–57.
   PubMedGoogle Scholar
• Arevalo-Herrera M, Lopez-Perez M, Medina L, et al. Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia. Malar J. 2015;14:154. 10.1186/s12936-015-0678-3
   PubMed Web of Science ®Google Scholar
• Kochar DK, Das A, Kochar SK, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009;80(2):194–198.
   PubMed Web of Science ®Google Scholar
• Kochar DK, Singh P, Agarwal P, et al. Malarial hepatitis. J Assoc Physicians India. 2003;51:1069–1072.
   PubMedGoogle Scholar
• Khan FY, El-Hiday AH. Acute acalculous cholecystitis complicating an imported case of mixed malaria caused by Plasmodium falciparum and Plasmodium vivax. Int J Infect Dis. 2010;14:e217–e219. 10.1016/j.ijid.2009.07.018
   Google Scholar
• Lacerda M, Mourão M, Alexandre M, et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J. 2012;11:12.
   Web of Science ®Google Scholar
• Leal-Santos FA, Silva SB, Crepaldi NP, et al. Altered platelet indices as potential markers of severe and complicated malaria caused by Plasmodium vivax: a cross-sectional descriptive study. Malar J. 2013;12(1):462. 10.1186/1475-2875-12-462
   PubMed Web of Science ®Google Scholar
• Gérardin P, Rogier C, Amadou SK, et al. Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg. 2002;66(6):686–691.
   PubMed Web of Science ®Google Scholar
• Singh R, Godson II, Singh S, et al. High prevalence of asymptomatic malaria in apparently healthy schoolchildren in Aliero, Kebbi state, Nigeria. J Vector Borne Dis. 2014;51(2):128–132.
   PubMed Web of Science ®Google Scholar
• Yuan L, Wang Y, Parker DM, et al. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar. Antimicrob Agents Chemother. 2015;59(2):1230–1235. 10.1128/AAC.04270-14
   PubMed Web of Science ®Google Scholar
• Price RN, von Seidlein L, Valecha N, et al. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(10):982–991. 10.1016/S1473-3099(14)70855-2
   PubMed Web of Science ®Google Scholar
• Lanca EF, Magalhaes BM, Vitor-Silva S, et al. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One. 2012;7(4):e35406. 10.1371/journal.pone.0035406
   Google Scholar